Researchers have discovered through a vast and novel computational library the first molecules that can modulate circadian rhythms by binding with high selectivity to the MT1 melatonin receptor in the biological clock.
The award recognizes UB’s progress in bringing the benefits of clinical and translational science to patients, including the tripling of clinical trials since 2015.
Researchers surveyed cannabis users about beliefs on marijuana's effectiveness in treating certain medical conditions. The results reveal a big discrepancy.